“Our life is March weather, savage and serene in one hour.” — Ralph Waldo Emerson
Substitute “biotechs” for “our life” and you have the investing version of Emerson’s quote. Depending on how binary events go, they can certainly become savage or serene quite quickly.We asked our team of experts for their top biotech picks to watch this month. Read below to […]
The biotech sector has started 2015 with the announcement of several deals. Both Kite Pharma (KITE – Snapshot Report) and Isis Pharmaceuticals (ISIS – Analyst Report) saw their share prices increasing on collaboration agreements with major companies. Meanwhile, Alkermes (ALKS – Analyst Report) has also started the year on a positive note with encouraging pipeline data.Recap of the Week’s Most […]
The number of patients with this chronic liver disease, which can lead to permanent liver scarring, eclipses that of hepatitis C in the U.S., RBC’s Yee said. While a significant number aren’t diagnosed, “we believe, based on survey work, that there are hundreds of thousands of patients with diagnosed NASH,” and that the global market for NASH drugs may reach […]
moreView todays social media effects on NASHView the latest stocks trending across Twitter. Click to view dashboardSee who Nashville is hiring next, click here to view […]
moreView todays social media effects on NASHView the latest stocks trending across Twitter. Click to view dashboardSee who Nashville is hiring next, click here to view […]
moreView todays social media effects on NASHView the latest stocks trending across Twitter. Click to view dashboardSee who Nashville is hiring next, click here to view […]
moreView todays social media effects on NASHView the latest stocks trending across Twitter. Click to view dashboardSee who Nashville is hiring next, click here to view […]
